New product information wording – Extracts from PRAC recommendations on signals adopted at the 13-16 May 2024 PRAC
New product information wording – Extracts from PRAC recommendations on signals adopted at the 13-16 May 2024 PRAC
New product information wording – Extracts from PRAC recommendations on signals adopted at the 13-16 May 2024 PRAC
PRAC recommendations on signals adopted at the 13-16 May 2024 PRAC meeting
List of signals discussed at PRAC since September 2012
EMEA-003184-PIP01-22
Agenda - Joint HMA/EMA Big Data Steering Group workshop on real-world evidence (RWE) methods
EMEA-003080-PIP03-22
Change management activities delivery plan
Workplan 2023-2025: HMA-EMA joint Big Data Steering Group
EMEA-002612-PIP02-22
Opinion/decision on a Paediatric investigation plan (PIP): Evusheld, tixagevimab,cilgavimab, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Infectious diseases, PIP number: P/0119/2023